IMAX CORP(IMAX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,253 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
IMAX Stock Analysis & AI Quality Score
AI stock analysis and institutional research for IMAX CORP (IMAX), a Technology sector company. 13F Pro's AI-powered ranking engine scores IMAX at 53.9/100 on a 32-signal composite quality model, placing it at rank #1,253 of 2,879 stocks — the top half of the AI-ranked universe. IMAX scores in the top quartile across free cash flow (82.6). Areas of concern include institutional flow (27.9) and revenue growth (31.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 22.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), IMAX CORP reports quarterly revenue of $81.4M, net income of $4.2M, free cash flow of $1.9M. Top institutional holders of IMAX by reported 13-F value include Orbis Allan Gray Ltd, NOMURA ASSET MANAGEMENT INTERNATIONAL, FMR, based on the most recent SEC filings. IMAX trades on the NYSE exchange and files with the SEC under CIK 921582. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IMAX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for IMAX CORP directly from SEC EDGAR.
Revenue
Q1 2026
$81.4M
Net Income
Q1 2026
$4.2M
Free Cash Flow
Q1 2026
$1.9M
ROIC
Q1 2026
3.0%
Get alerted when IMAX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for IMAX CORP including:
Top Institutional Holders of IMAX
Orbis Allan Gray Ltd
$195.8M5,151,721 shNOMURA ASSET MANAGEMENT INTERNATIONAL INC.
$140.8M3,704,207 shFMR LLC
$118.5M3,117,374 shBlackRock, Inc.
$99.7M2,622,590 shWESTFIELD CAPITAL MANAGEMENT CO LP
$88.9M2,338,776 shDRIEHAUS CAPITAL MANAGEMENT LLC
$62.8M1,651,711 shCONGRESS ASSET MANAGEMENT CO /MA
$57.4M1,510,375 shAMERIPRISE FINANCIAL INC
$50.5M1,328,595 shROYCE & ASSOCIATES LP
$47.4M1,246,240 shDIMENSIONAL FUND ADVISORS LP
$47.0M1,237,230 sh
| Fund | Value | Shares |
|---|---|---|
| Orbis Allan Gray Ltd | $195.8M | 5,151,721 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $140.8M | 3,704,207 |
| FMR LLC | $118.5M | 3,117,374 |
| BlackRock, Inc. | $99.7M | 2,622,590 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $88.9M | 2,338,776 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | $62.8M | 1,651,711 |
| CONGRESS ASSET MANAGEMENT CO /MA | $57.4M | 1,510,375 |
| AMERIPRISE FINANCIAL INC | $50.5M | 1,328,595 |
| ROYCE & ASSOCIATES LP | $47.4M | 1,246,240 |
| DIMENSIONAL FUND ADVISORS LP | $47.0M | 1,237,230 |
More Technology Companies
View all Technology →Put IMAX on your watchlist
Track score changes the day IMAX CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is IMAX a good stock to buy?
13F Pro's AI-powered analysis of IMAX CORP (IMAX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Technology sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for IMAX are available on the IMAX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own IMAX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling IMAX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of IMAX CORP's investment landscape.